论文部分内容阅读
目的:研究分析干扰素复合治疗慢性丙型病毒性肝炎的临床治疗效果。方法:选择2012年1月至2015年1月该院进行治疗的100例慢性丙型病毒性肝炎患者为研究对象,将其随机分为观察组和对照组,每组各50例患者,给予对照组患者采用聚乙二醇干扰素和利巴韦林进行治疗,观察组患者在其基础上添加苦参进行干扰素复合治疗,观察两组患者的治疗效果。结果:治疗后,观察组患者的治疗效果和不良反应的发生率均显著优于对照组,差异具有统计学意义(P<0.05)。结论:采用干扰素复合治疗能够有效的提高慢性丙型病毒性肝炎患者的治疗效果,降低治疗过程中患者的不良反应,具有临床推广的应用价值。
Objective: To study the clinical effect of interferon complex therapy on chronic hepatitis C virus. Methods: One hundred patients with chronic hepatitis C who were treated in our hospital from January 2012 to January 2015 were selected as study subjects. They were randomly divided into observation group and control group, with 50 cases in each group. The patients were treated with peginterferon and ribavirin. The patients in the observation group were treated with interferon on the basis of Sophora flavescens, and the therapeutic effects were observed in both groups. Results: After treatment, the treatment group and the incidence of adverse reactions were significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion: The combination therapy with interferon can effectively improve the therapeutic effect of patients with chronic hepatitis C and reduce the adverse reactions of patients during treatment, which has the clinical value of application.